SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-035267
Filing Date
2020-11-05
Accepted
2020-11-05 16:01:22
Documents
51
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0920_silopharmainc.htm 10-Q 624254
2 CERTIFICATION f10q0920ex31-1_silopharmainc.htm EX-31.1 16592
3 CERTIFICATION f10q0920ex32-1_silopharmainc.htm EX-32.1 7298
  Complete submission text file 0001213900-20-035267.txt   3113968

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE silo-20200930.xml EX-101.INS 431817
5 XBRL SCHEMA FILE silo-20200930.xsd EX-101.SCH 39543
6 XBRL CALCULATION FILE silo-20200930_cal.xml EX-101.CAL 44206
7 XBRL DEFINITION FILE silo-20200930_def.xml EX-101.DEF 125798
8 XBRL LABEL FILE silo-20200930_lab.xml EX-101.LAB 271447
9 XBRL PRESENTATION FILE silo-20200930_pre.xml EX-101.PRE 205337
Mailing Address 1086 TEANECK ROAD SUITE 3A TEANECK NJ 07666
Business Address 1086 TEANECK ROAD SUITE 3A TEANECK NJ 07666 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54872 | Film No.: 201290306
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl